Biological and Pharmaceutical Bulletin
Online ISSN : 1347-5215
Print ISSN : 0918-6158
ISSN-L : 0918-6158
Regular Articles
Involvement of the Peripheral μ-Opioid Receptor in Tramadol-Induced Constipation in Rodents
Kana YasufukuKatsumi KoikeMika KobayashiHiroki ChibaMotoji KitauraShino TakenouchiMinoru HasegawaYasuhide MoriokaHirokazu MishimaTsutomu SuzukiMasahide Fujita
Author information
JOURNAL FREE ACCESS FULL-TEXT HTML

2021 Volume 44 Issue 11 Pages 1746-1751

Details
Abstract

Tramadol is a weak opioid that produces analgesic effect via both the μ-opioid receptor (MOR) and non-opioid targets. Constipation is the most common opioid-related side effect in patients with cancer and non-cancer pain. However, the contribution of MOR to tramadol-induced constipation is unclear. Therefore, we used naldemedine, a peripherally acting MOR antagonist, and MOR-knockout mice to investigate the involvement of peripheral MOR in tramadol-induced constipation using a small intestinal transit model. A single dose of tramadol (3–100 mg/kg, per os (p.o.)) inhibited small intestinal transit dose-dependently in rats. Naldemedine (0.01–10 mg/kg, p.o.) blocked the inhibition of small intestinal transit induced by tramadol (30 mg/kg, p.o.) in rats. The transition rate increased dose-dependently over the range of naldemedine 0.01–0.3 mg/kg, and complete recovery was observed at 0.3–10 m/kg. Additionally, tramadol (30 and 100 mg/kg, subcutaneously (s.c.)) inhibited small intestinal transit in wild-type mice but not in MOR-knockout mice. These results suggest that peripheral MOR participates in tramadol-induced constipation.

Fullsize Image
Content from these authors
© 2021 The Pharmaceutical Society of Japan
Previous article Next article
feedback
Top